Dendritic cells (DC) are important antigen-presenting cells (APC) involved in initiating and modulating T-cell-mediated immune responses (reviewed in references 2 and 3). DC progenitors arise in the bone marrow, and through transport via the blood, they enter tissues. Murine DC from various tissues and organs share related features such as surface expression of the CD11c p150/90 integrin and constitutive expression of major histocompatibility complex class II molecules (MHC-II) and costimulatory molecules. In general, DC found in peripheral sites such as skin and mucosal surfaces are in an immature stage. That is, they are optimized for capturing and processing antigens but are relatively poor stimulators of naïve T cells (3, 36). Exposure to antigen and inflammatory stimuli initiates a maturation process whereby immature DC become effective activators of T cells and are directed to sites of lymphocyte priming (3, 15, 18, 21, 36) .
T cells. Finally, DC that phagocytosed live or heat-killed Salmonella in vitro primed bacterium-specific IFN-␥-producing CD4
؉ and CD8
؉ T cells as well as cytolytic effector cells following administration into naïve mice. Together these data suggest that DC are involved in priming naïve T cells to Salmonella in vivo.
Dendritic cells (DC) are important antigen-presenting cells (APC) involved in initiating and modulating T-cell-mediated immune responses (reviewed in references 2 and 3). DC progenitors arise in the bone marrow, and through transport via the blood, they enter tissues. Murine DC from various tissues and organs share related features such as surface expression of the CD11c p150/90 integrin and constitutive expression of major histocompatibility complex class II molecules (MHC-II) and costimulatory molecules. In general, DC found in peripheral sites such as skin and mucosal surfaces are in an immature stage. That is, they are optimized for capturing and processing antigens but are relatively poor stimulators of naïve T cells (3, 36) . Exposure to antigen and inflammatory stimuli initiates a maturation process whereby immature DC become effective activators of T cells and are directed to sites of lymphocyte priming (3, 15, 18, 21, 36) .
Although the role of DC in priming naïve T cells to protein antigens is well established (36) , a remaining unanswered question relates to the role of this APC relative to other phagocytic APC, such as macrophages (M⌽), in triggering bacteriumspecific T cells following bacterial internalization in vivo. Using Salmonella enterica serovar Typhimurium as a model bacterium, it has been shown that both M⌽ and immature DC can present antigens processed from this facultative intracellular gram-negative bacterium and induce DC maturation in vitro (33, 37, 39, (44) (45) (46) . The ability of S. enterica serovar Typhimurium to reside and replicate within phagosomes of phagocytic cells (4, 7, 26) makes this an interesting model to study bacterial interaction with APC in vivo. For example, S. enterica serovar Typhimurium has been found in CD18-expressing cells (34, 42) , which include various APC populations (35) . The bacterium has also been shown to be associated with CD11c ϩ cells of FLT3-L-treated mice (22) and within CD11c ϩ cells of the subepithelial dome overlying Peyer's patches following administration of bacteria (12) . However, despite its association with various phagocytic populations in vivo, and the well-characterized role of T cells in host defense against Salmonella (11, 23, 27, 31, 43) , the nature of the APC that primes Salmonellaspecific T cells during infection, particularly naïve T cells, is not clear.
The present study addresses the role of DC as APC involved in the specific immune response to S. enterica serovar Typhimurium in vivo. Following a single administration of Salmonella expressing green fluorescent protein (GFP), GFP-positive (GFP ϩ ) cells among CD11c ϩ MHC-II ϩ splenocytes were apparent, and confocal microscopy showed that bacteria were inside splenic DC (CD11c ϩ MHC-II ϩ cells). In addition, increased surface expression of activation markers on both DC and T cells occurred following a single dose of bacteria, and Salmonella-specific CD4 ϩ and CD8 ϩ effector T cells were generated. Finally, DC loaded with Salmonella elicited specific effector T cells following injection into naïve hosts. Together these data support a role for DC in eliciting specific antiSalmonella immunity.
MATERIALS AND METHODS
Mice. C57BL/6 mice were bred and maintained in the animal facilities at Lund University (Lund, Sweden) and were offered food and water ad libitum. All mice were age matched and used at 8 to 12 weeks of age.
Bacterial strains and culture conditions. S. enterica serovar Typhimurium 4550 (SR11 pStSR100 ϩ gyrA1816 ⌬crp-1 ⌬asdA1 ⌬cya-1) was used as a host for expression of the model antigen ovalbumin (OVA) in the vector pYA3259. pYA3259 is a pUCI8-derived plasmid encoding a truncated form of aspartate ␤-semialdehyde dehydrogenase (ASD). ASD is an enzyme in the biosynthetic pathway for diaminopimelic acid (DAP), an essential component of the peptidoglycan of the bacterial cell wall; asd mutant bacteria undergo lysis in the absence of DAP. As DAP is not present in mammalian tissues, use of an ⌬asdA1-ASD ϩ host-vector pair allows plasmid maintenance in vivo in the absence of antibiotic selection (8, 30) .
OVA was cloned into pYA3259 by amplifying a 1.2-kb fragment encoding OVA from the cDNA contained in pOV230 (24) . The oligonucleotide primers incorporated an EcoRI site and a Shine-Dalgarno sequence 5Ј of the OVA start codon and a BamHI site 3Ј of the stop codon. The fragment was cloned into the corresponding sites of pYA3259, resulting in the plasmid pYA3259-OVA. GFP was cloned into pYA3259-OVA by digesting pSK-XhoGFP (40) with Xho and purifying the 0.9-kb fragment encoding GFP after agarose gel electrophoresis. This fragment was subsequently ligated into SalI-digested pYA3259-OVA to create pYA3259-OVA-GFP. S. enterica serovar Typhimurium 4550 harboring pYA3259, called 4550; S. enterica serovar Typhimurium 4550 harboring pYA3259-OVA, called 4550 OVA; and S. enterica serovar Typhimurium 4550 harboring pYA3259-OVA-GFP, called 4550 OVA-GFP, were used in these studies. Bacteria were grown overnight at 37°C with shaking in Luria-Bertani (LB) broth and were quantitated spectrophotometrically by determining the optical density at 600 nm. The bacteria were then centrifuged at 2,300 ϫ g for 5 min and resuspended in Iscove's modified Dulbecco's medium (IMDM) (Life Technologies, Gaithersburg, Md.) without antibiotics. The quantity of live bacteria actually given to mice was determined by viable plate counts. Heat-killed bacteria were prepared by incubating a bacterial suspension at 65°C for 40 min. Loss of bacterial viability was confirmed by plating an aliquot of heat-killed bacteria on LB agar plates.
Immunization of mice. In experiments where DC interactions with GFPexpressing bacteria were studied, mice were given a single intravenous or intraperitoneal (i.p.) injection of 6 ϫ 10 8 live or 3 ϫ 10 9 heat-killed 4550 OVA-GFP and were sacrificed 4 h later. In experiments where DC and T-cell activation were analyzed, mice were given a single i.p. injection of 10 6 live or heat-killed 4550 OVA and were sacrificed 14 days later. In experiments where Salmonella-loaded DC were used (see below), mice were given either 10 6 DC incubated in medium alone (control DC), 10 6 DC loaded with live 4550, or 10 6 DC loaded with live or heat-killed 4550 OVA (see below). Mice received two i.p injections 1 week apart and were sacrificed 14 days after the last administration. The spleens from immunized animals were used to isolate DC as described below or were homogenized to analyze effector cell functions. Enriched DC or total splenocytes were used in flow cytometry analysis, and total splenocytes were used in intracellular cytokine staining and cytotoxic T-cell assays. The number of bacteria remaining in the spleen of mice was determined by lysing 10 7 spleen cells in 0.1% Triton X-100 in phosphate-buffered saline and plating on LB agar plates.
Isolation of splenic DC. In experiments where splenic DC were purified from mice given GFP-expressing Salmonella, all steps were carried out on ice to avoid ex vivo bacterial uptake. The spleens from immunized animals were homogenized, red blood cells were lysed, and cell suspensions were washed once in Hanks buffered salt solution (HBSS). Then, splenic CD11c-expressing cells were enriched using N418 magnetic beads and MiniMACS columns (Miltenyi Biotech GmbH, Bergisch Gladbach, Germany) following the manufacturer's protocol. Cell suspensions were incubated with N418 magnetic beads for 15 min in phosphate-buffered saline containing 3% fetal calf serum (FCS) and 2 mM EDTA at 4°C. Magnetically labeled cells were then added on a column, and trapped cells were flushed out to be used in flow cytometry or confocal microscopy. The enriched population consisted of approximately 80 to 90% CD11c ϩ cells as determined by the antibody N418 (anti-CD11c) or HL3 (anti-CD11c) in flow cytometry analysis (see below).
Flow cytometry. Flow cytometry analysis was performed using a FACS Calibur flow cytometer (Becton Dickinson & Co., Mountain View, Calif.). Antibodies from hybridomas 2.4.G2 (anti-FcR␥II/III), N418 (anti-CD11c), M5/114 (anti-MHC-II), and GK1.5 (anti-CD4) (reference 37 and references therein), as well as 145.2C11 (anti-CD3 [17] ), YTS.169 (anti-CD8␣ [5] ), F4/80 (anti-F4/80 [1] ), and RA6-3A2 (anti-B220 [6] ), were used. Antibodies were purified from supernatants using ␥-bind plus columns (Pharmacia-Biotech, Uppsala, Sweden) and were labeled with biotin (Sigma Chemical Co, St. Louis, Mo.), fluorescein isothiocyanate (FITC) (Sigma), or Cy5 (Amersham Pharmacia Biotech, Uppsala, Sweden). Biotinylated anti-GR-1 as well as phycoerythrin (PE)-labeled anti-CD4, -CD8, -CD11c, -CD40, -CD86, -B220, and -MHC-II antibodies were purchased from Pharmingen (San Diego, Calif.). Streptavidin-allophycocyanin (Pharmingen) was used as the second-step reagent. Dead cells were excluded by staining with 7-amino-actinomycin D (7AAD) (Sigma). Incubations with antibodies or reagents for surface staining were performed for 20 min on ice in HBSS (Life Technologies) containing 3% FCS, 2 mM EDTA, and 0.01% sodium azide.
Confocal microscopy. For confocal microscopy studies, cells were kept on ice at all possible steps and cold buffers and reagents were used. MACS columnpurified CD11c ϩ cells were stained on ice with anti-CD11c-Cy5 and anti-MHC-II-biotin followed by Streptavidin-Alexa Fluor 594 (Molecular Probes, Leiden, The Netherlands). The cells were fixed in 1% paraformaldehyde on ice for 30 min and then at room temperature for another 30 min before being added onto polylysine-treated slides and mounted with ProLong Antifade (Molecular Probes). The cells were inspected by epifluorescence and laser scanning confocal microscopy using MRC-1024 confocal equipment (Bio-Rad Laboratories, Hemel-Hampstead, United Kingdom) attached to a Nikon Eclipse E800 upright microscope (Nikon, Tokyo, Japan) using a band-pass filter (522 Ϯ 32 nm) to detect green fluorescence, another band-pass filter (598 Ϯ 40 nm) to detect red fluorescence, and another band-pass filter (680 Ϯ 32 nm) to detect far-red fluorescence.
Cell culture conditions and in vitro infections of DC. DC were cultured from C57BL/6 bone marrow as described elsewhere (39, 40) . Briefly, on days 6 to 7 of culture in IMDM supplemented with 5% FCS and granulocyte-macrophage colony-stimulating factor, the CD11c-expressing population was enriched using N418 magnetic beads (Miltenyi Biotech GmbH). The enriched population consisted of approximately 90% MHC-II ϩ , CD86 ϩ , and CD11c ϩ cells as determined by the antibodies M5/114 (anti-I-A b ), GL-1 (anti-CD86), and N418 (anti-CD11c) or HL3 (anti-CD11c) in flow cytometry analysis. Purified DC were resuspended in IMDM (without antibiotics) containing 5% FCS and granulocyte-macrophage colony-stimulating factor and seeded at 10 6 cells per well in 24-well plates (Ultra Low Cluster plates; Costar Corning Corp., Cambridge Mass.). The cells were then infected with live or heat-killed bacteria at a bacteria/DC ratio of 50:1. The 24-well plates were centrifuged at 270 ϫ g for 5 min. Some wells containing DC were incubated in IMDM containing 5% FCS for use as control DC. DC were incubated for 2 h at 37°C, were washed three times with HBSS, and were incubated for an additional 2 h at 37°C in IMDM containing 5% FCS and gentamicin (50 g/ml). The cells were washed once in HBSS and were resuspended in HBSS (without antibiotics). They were then used either to inject into mice or to restimulate splenocytes. The effective dose of live bacteria given to mice by administering DC loaded with bacteria was approximately 10 6 as determined by lysing aliquots of Salmonella-loaded DC in 0.1% Triton X-100 in phosphate-buffered saline and plating on LB agar plates. In some experiments, samples of DC infected with bacteria were transferred to 96-well plates, were fixed in 1% paraformaldehyde, and presentation of OVA(257-264)/K b and OVA(265-280)/I-A b complexes processed from 4550 OVA to CD8OVA or OT4H.2D5 T hybridoma cells, respectively, was quantitated as described previously (37) .
Intracellular cytokine staining. Gamma interferon (IFN-␥) production by splenocytes was determined by intracellular cytokine staining and flow cytometry analysis. Briefly, 2 ϫ 10 7 spleen cells from individual immunized mice were cultured with DC incubated in medium alone or with DC loaded with heat-killed bacteria in 3 ml of IMDM supplemented with 10% FCS. Incubations were at 37°C and 5% CO 2 for a total of 24 h. The splenocyte to DC ratio was 20:1. Four hours prior to the end of the incubation, brefeldin A was added to a concentration 5 g/ml. Brefeldin A-treated cells were labeled with anti-T-cell receptor ␣␤ (anti-TCR␣␤), and with either anti-CD4 or anti-CD8 antibodies as described above and were fixed in 2% paraformaldehyde for 20 min at room temperature. Fixed cells were permeabilized in HBSS containing 3% FCS (Sigma), 0.5% saponin (Sigma), and 0.05% azide for 20 min at room temperature. Permeabilized cells were stained with anti-IFN-␥-FITC (Pharmingen) or with FITC-labeled isotype-matched control antibodies (Pharmingen) for 30 min at room temperature. Flow cytometry was performed on splenocytes from individual mice stimulated separately.
Cytotoxic T-cell assays. Cytotoxic T-cell activity in the spleens of mice given 4550 OVA was determined by coculturing 25 ϫ 10 6 spleen cells from individual mice with 12.5 ϫ 10 6 irradiated syngeneic spleen cells in the presence of 100 nM OVA(257-264) peptide in 12 ml of IMDM supplemented with 10% FCS and antibiotics at 37°C and 5% CO 2 for 5 days. Cell-mediated lysis was subsequently measured in standard 51 Cr release assays on splenocytes from individual mice cultured and assayed separately. Briefly, target cells were prepared by loading EL4 cells with 50 M OVA(257-264) peptide for 60 min at 37°C. Titrated amounts of restimulated effector cells were incubated with 10 4 51 Cr-labeled target cells for 5 h at 37°C in a total volume of 100 l. Following the incubation, 25 l of supernatant was collected and counted in a Wallac 1450 MicroBeta counter (Wallac Oy, Turku, Finland) to quantitate the amount of released 51 Cr. The maximum release of 51 Cr was determined by addition of 1% sodium dodecyl sulfate to 51 Cr-labeled target cells. The mean number of counts per minute was calculated from triplicate wells. The percent specific cytotoxicity was calculated according to the following formula: [(mean cpm test cell release Ϫ mean cpm spontaneous release) Ϭ (mean cpm maximum release Ϫ mean cpm spontaneous release)] ϫ 100, where cpm is counts per minute.
RESULTS
S. enterica serovar Typhimurium association with splenic phagocytic cell subsets during infection. To assess the splenic phagocytic cell subpopulations that interact with S. enterica serovar Typhimurium upon infection of mice, flow cytometry was performed on splenocytes 4 h after i.p. or intravenous administration of 4550 OVA-GFP. Several populations of phagocytic cells including CD11c ϩ MHC-II ϩ cells were GFP ϩ , suggesting that DC associated with the bacteria in vivo using either route of administration ( Fig. 1a and Table 1 ). CD11c ϩ MHC-II ϩ cells were also GFP ϩ following administration of heat-killed 4550 OVA-GFP, although the percentage of GFP ϩ cells was consistently lower in mice given heat-killed bacteria (Fig. 1a) . This could be partly due to the somewhat lower GFP fluorescence detected after heat killing the bacteria (Fig. 1b) .
Two findings support the argument that the GFP fluores- cence of splenocytes was due to uptake of 4550 OVA-GFP by phagocytic cells rather than nonspecific binding of the bacteria to the cell surface. First, fluorescent confocal microscopy showed that GFP ϩ bacteria were indeed contained within CD11c ϩ MHC-II ϩ cells (Fig. 2) . Second, further characterization of the GFP ϩ cell populations revealed that little, if any, GFP fluorescence was associated with nonphagocytic cells such as CD11c
Ϫ CD3 ϩ cells (T lymphocytes) ( Table 1) . Furthermore, GFP fluorescence associated with CD11c Ϫ B220 ϩ B lymphocytes was only apparent at a very high dose of administered bacteria (Table 1) . Within other CD11c
Ϫ cell populations, namely, non-DC populations, significant GFP fluorescence was associated with cells that stained positive for GR-1 and F4/80. The former surface marker on CD11c
Ϫ cells is associated with granulocytes (16) (Table 1) .
DC and T-cell activation in response to Salmonella infection. As Salmonella is contained within splenic DC in vivo (Fig. 2) , and as these cells are the most efficient APC type capable of stimulating naïve T cells (2, 3, 36) , we investigated the activation state of both DC and T cells in infected mice. Mice were given a single dose of live 4550 OVA, and 14 days later splenic DC were analyzed for surface molecule expression. Flow cytometry revealed that the CD11c ϩ MHC-II ϩ cells had increased expression of CD86 and CD40 (Fig. 3) as well as a small but consistent increase in CD80 expression (data not shown). No effect was apparent on DC from mice that received heat-killed 4550 OVA (Fig. 3) .
Surface expression of the activation markers CD44 and CD69 was also increased on splenic T cells from Salmonellainfected mice, where more cells expressing high levels of CD44 and CD69 were present in both CD4
ϩ and CD8 ϩ cell populations following a single administration of live bacteria (Fig.  4) . In contrast, little, if any, effect on CD44 and CD69 expression on splenic T cells was apparent in mice that received heat-killed bacteria. Together these data show that a single dose of live but not heat-killed S. enterica serovar Typhimurium results in a significant increase in costimulatory molecule expression on splenic DC and increased expression of CD44 and CD69 activation markers on CD4 ϩ and CD8 ϩ splenic T cells.
IFN-␥-producing CD4
؉ and CD8 ؉ T cells are elicited in Salmonella-infected mice. T cells are a critical component of the specific immune response to S. enterica serovar Typhimurium, and bacterium-specific CD4 ϩ and CD8 ϩ effector T cells are elicited following infection (reviewed in references 27 and 44). Although previous studies have enumerated Salmonella-specific IFN-␥-producing CD4 ϩ T cells by enzyme-linked immunosorbent spot assay following a 2-to 4-day restimulation of splenocytes from infected mice (25, 32, 41) , neither the frequency of Salmonella-specific IFN-␥-producing CD4 ϩ T cells following a brief ex vivo restimulation nor the frequency of CD8 ϩ T cells that specifically contribute to IFN-␥ production in infected mice have been quantitated. Thus, flow cytometry analysis was performed on splenocytes from mice given 4550 OVA. Upon restimulation for 24 h, the cells were stained for surface expression of TCR␣␤ and either CD4 or CD8 as well as intracellular IFN-␥. These data revealed that 
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Salmonella-specific IFN-␥-producing CD4 ϩ as well as CD8 ϩ T cells were generated in mice given 4550 OVA once (Fig. 5) . In contrast, no Salmonella-specific IFN-␥-producing CD4 ϩ T cells (Ͻ0.1%) and few if any IFN-␥-producing CD8 ϩ T cells (0.2%) were apparent in mice receiving heat-killed bacteria once (Fig. 5) or twice (one week apart; data not shown).
Salmonella-loaded DC generate bacteria-specific effector T cells in recipient mice. As it previously has been shown that immature DC can internalize and present Salmonella-derived antigens on MHC-I and MHC-II in vitro (39, 45), we addressed the question of whether these DC loaded with Salmonella in vitro could prime bacterium-specific T cells in vivo. Flow cytometry analysis of splenocytes harvested from mice given DC loaded with 4550 OVA showed that both CD4 ϩ and CD8 ϩ cells produced Salmonella-specific IFN-␥ following in vitro restimulation (Fig. 6a) . The CD4 ϩ population consisted of a higher frequency of Salmonella-specific IFN-␥-producing cells than the CD8 ϩ population. In addition, splenocytes from mice that received DC loaded with bacteria in the presence of cytochalasin D generated undetectable levels of specific IFN-␥-producing CD4 ϩ or CD8 ϩ T cells (data not shown). This demonstrates that bacteria contained within the DC, rather than bacteria adhering to the outer surface of the cells, were responsible for eliciting Salmonella-specific T cells. Specific cytolytic activity was also elicited in recipient mice. That is, splenocytes from mice given DC loaded with 4550 OVA and restimulated with irradiated syngeneic spleen cells in the presence of the OVA(257-264) peptide lysed EL4 target cells pulsed with the same peptide (Fig. 6b) . In contrast, little if any lysis of OVA(257-264)-loaded target cells was apparent when splenocytes from mice receiving control DC or DC loaded with 4550 not expressing OVA were restimulated and used as effector cells in 51 Cr release assays (Fig. 6b) . Interestingly, we consistently observed that the percent specific lysis elicited in mice given DC loaded with 4550 OVA was higher than that observed in mice given 4550 OVA as free bacteria.
This occurred despite the fact that both administrations contained similar amounts of live bacteria (ϳ10 6 ) (Fig. 6b) . In addition, the spleens from mice that received either type of administration had similar numbers of CFU at the time of sacrifice (see below) and never exceeded a difference of twofold.
As the DC used in these studies were loaded with live bacteria, it was possible that live bacteria released from the DC contributed to generating the observed effector T cells. Despite the fact that the spleens of mice contained few viable bacteria at the time of sacrifice (ϳ100 to 1,000 total bacteria), we performed experiments in which mice were injected with DC loaded with heat-killed 4550 OVA to eliminate any contribution of live bacteria in eliciting Salmonella-specific T cells. Despite the absence of viable bacteria in the DC used for the injections (as tested by viable plate counts on the heat-killed bacteria and an aliquot of the injected DC; data not shown), Salmonella-specific IFN-␥-producing CD4 ϩ and CD8 ϩ cells were generated (Fig. 7a) . In addition, OVA(257-264)-specific cytolytic effector cells were also generated in mice given DC loaded with heat-killed 4550 OVA (Fig. 7b) . Thus, DC loaded with 4550 OVA elicited bacterium-specific CD4 ϩ and CD8 ϩ effector T cells in recipient mice, and this did not require that the DC contain live bacteria.
DISCUSSION
The importance of peripheral DC in capturing exogenous soluble antigens and migrating to draining lymph nodes where they prime naïve T cells is well established (15, 18, 21, 36) . In contrast, the role of immature DC in capturing intact microbes encountered in the periphery and their subsequent migration to draining lymph nodes for T-cell priming is not well characterized, with the exception of cutaneous infection with Leishmania major (28, 29) . Thus, the APC type(s) that phagocytose gram-negative bacteria, such as S. enterica serovar Typhi- murium, and prime Salmonella-specific T cells in secondary lymphoid organs in vivo is not clear.
In the present study we show that the three major phagocytic cell types, neutrophils, macrophages, and DC, all associate with GFP-expressing Salmonella in vivo. These phagocytic cells may be involved in controlling bacterial replication and/or producing proinflammatory cytokines (37, 38) . As the latter may influence the subsequent recruitment and activation of cells of the innate as well as the adaptive immune response, it is clear that the interplay between phagocytic cells harboring bacteria is complex. However, DC have a superior capacity to stimulate naïve T cells (36) . This, combined with our data showing that splenic CD11c ϩ MHC-II ϩ DC internalize Salmonella in vivo, suggests that DC may be involved in priming bacterium-specific T cells. Furthermore, we show that splenic DC have increased surface expression of CD40 and CD86 following administration of live Salmonella, which augments their capacity to productively interact with T cells. The activation of DC following bacterial administration was likely not due to a general effect of lipopolysaccharide. This is supported by data showing that the surface expression of CD40 and CD86 on splenic CD11c
Ϫ B220 ϩ B cells, which are polyclonally activated in mice injected with lipopolysaccharide isolated from Salmonella (13), was identical in naïve mice and in mice that received 4550 14 days earlier (data not shown).
Infection with live S. enterica serovar Typhimurium resulted in broad activation of CD4 ϩ and CD8 ϩ T cells and generation of Salmonella-specific IFN-␥-producing T cells in both of these subsets. Although the specificity of the broadly activated T cells is not clear, it is likely that not all of these cells are bacterium specific; at least some of the increased CD44 and CD69 expression may reflect bystander activation. Generation of bacterium-specific IFN-␥-producing CD4 ϩ and CD8 ϩ T cells is consistent with the critical role of TCR␣␤ ϩ cells, particularly the CD4 ϩ subset, and IFN-␥ in immunity to Salmonella (reviewed in reference 27). Our data revealed that the frequency of specific IFN-␥-producing CD4 ϩ T cells was significantly greater than that of CD8 ϩ cells in mice given a single dose of live Salmonella. This is the first quantitation of the frequency of Salmonella-specific CD4 ϩ versus CD8 ϩ cells producing IFN-␥ during infection of the same animal and supports the argument that the predominant source of IFN-␥ production by cells of the specific immune response is CD4 ϩ T cells. Although Salmonella-specific IFN-␥-producing CD8 ϩ T cells are elicited following infection with live bacteria, the contribution of IFN-␥ production by specific CD8
ϩ T cells appears to FIG. 4 . CD44 and CD69 surface expression is enhanced on CD4 ϩ and CD8 ϩ splenic T cells from mice given a single dose of 4550 OVA. Mice were given 2.5 ϫ 10 6 live or heat-killed 4550 OVA i.p. Two weeks later, splenocytes from individual mice were stained with 7AAD, Allophycocyanin-conjugated TCR␣␤, and either FITC-conjugated anti-CD4 or anti-CD8. Cells were subsequently stained with either PE-conjugated anti-CD44 or anti-CD69. The top two histograms show CD44 and CD69 expression on gated TCR␣␤ ϩ CD4 ϩ cells, while the bottom histograms show CD44 and CD69 expression on gated TCR␣␤ ϩ CD8 ϩ cells from the spleens of mice given either live (thick line) or heat-killed (dotted line) 4550 OVA. The x axes represent log fluorescence intensity, while the y axes represent the number of gated events as indicated. CD44 and CD69 expression on gated CD4 ϩ and CD8 ϩ T cells from untreated mice (thin line) is shown for comparison. A total of 10,000 gated T cells were analyzed for CD44 or CD69 expression. The results shown are from individual mice and are representative of seven independent experiments with a total of nine mice per group. Appropriate isotype subclass control antibodies showed no significant staining on gated CD4 ϩ and CD8 ϩ splenocytes.
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on October 14, 2017 by guest http://iai.asm.org/ be minor relative to that produced by CD4 ϩ T cells. This suggests that the importance of the elicited specific CD8 ϩ T cells may be in their cytolytic function rather than IFN-␥ production.
Studies in ␤ 2 m Ϫ/Ϫ mice showed that clearance of an avirulent S. enterica serovar Typhimurium strain occurred independently of CD8 ϩ T cells (11) , while CD8 ϩ T cells were important in clearing a virulent strain (20) . The present study demonstrates that cytolytic CD8 ϩ T cells are elicited following infection with S. enterica serovar Typhimurium, supporting previous reports (reviewed in reference 44). It has also been shown that cytolytic CD8 ϩ T-cell activity restricted to the nonclassical MHC-I molecule Qa-1 is generated in mice primed with an avirulent strain and then challenged with a virulent strain (20) . However, in preliminary experiments, we were unable to demonstrate Salmonella-specific IFN-␥-producing CD8 ϩ splenocytes from C57BL/6 mice given a single dose of 4550 following restimulation with DC from MHC-mismatched (BALB/c) mice loaded with 4550. This suggests that the IFN-␥-producing CD8 ϩ cells analyzed in the present study are restricted to classical MHC-I molecules rather than class Ib molecules shared by C57BL/6 and BALB/c mice.
Poor immunity in mice receiving heat-killed S. enterica serovar Typhimurium has been documented for nearly 30 years (10). However, only limited data are available on the defects in the specific immune response that could account for the poor immunogenicity of heat-killed bacteria (9) . Our data show that heat-killed bacteria associate with DC and other phagocytic cells in vivo. However, administration of 5 to 10 times more heat-killed than live bacteria was required to observe a quantatively similar association of bacteria by phagocytic cells. In addition, immunization with 10 6 heat-killed bacteria did not result in up regulation of CD86 or CD40 on splenic DC analyzed 2 weeks after bacterial administration. This is in contrast to the increased expression of these costimulatory molecules on splenic DC from mice given the same dose of live bacteria. Furthermore, an increase in the total number of CD11c ϩ splenocytes was present in mice infected with live Salmonella (14) , while no such increase was present in mice given heatkilled bacteria (data not shown).
Significant T-cell activation was also not apparent following administration of killed bacteria. That is, CD44 and CD69 expression were not increased on CD4 ϩ or CD8 ϩ T cells, and IFN-␥-producing Salmonella-specific CD4 ϩ T cells were not detectable at time points when T-cell activation peaked in mice given the same amount of live bacteria. However, very low, albeit reproducible, levels of bacterium-specific CD8 ϩ cells producing IFN-␥ were apparent following administration of heat-killed 4550. The poor ability of heat-killed Salmonella to elicit specific T cells is not due to an inherent inability of DC to process heat-killed S. enterica serovar Typhimurium for peptide presentation on either MHC-I or MHC-II (37, 46) . Lower capacity to access the spleen, an inability to recruit and activate DC and/or an inferior ability to elicit a significant number of specific IFN-␥ producing T cells, particularly CD4 ϩ T cells, may contribute to the inferior capacity of heat-killed bacteria to elicit anti-Salmonella immunity.
DC contain Salmonella during infection (Fig. 2) , and immature DC can internalize and process live or heat-killed S. enterica serovar Typhimurium for presentation of Salmonellaencoded antigens on MHC-I and MHC-II (37, 39, 45, 46) . We therefore assessed the role of DC in priming naïve CD4 ϩ and CD8 ϩ T cells to Salmonella antigens in vivo by evaluating bacterium-specific effector T cells in mice given Salmonellaloaded DC. DC loaded with heat-killed bacteria were used to eliminate any contribution of viable bacteria residing in the host in eliciting Salmonella-specific T cells. DC harboring either live or killed S. enterica serovar Typhimurium primed both CD4 ϩ and CD8 ϩ T cells specific for bacterial antigens when administered to naïve mice. This occurred despite the fact that one-third fewer bacteria were present in DC loaded with heatkilled bacteria compared to DC loaded with live bacteria as measured by flow cytometry following uptake of GFP-expressing bacteria. Interestingly, administering DC loaded with heat- killed bacteria elicited a higher frequency of specific CD8 ϩ T cells producing IFN-␥ than CD4 ϩ T cells producing this cytokine in the same animal. In contrast, the frequency of bacterium-specific IFN-␥-producing CD4 ϩ T cells in a mouse given DC loaded with live bacteria was consistently greater than the frequency of specific CD8 ϩ T cells producing IFN-␥ in the same host. These data are consistent with the trend observed in mice given either live or heat-killed bacteria not contained within DC.
Our data also show that the frequency of IFN-␥-producing CD4 ϩ or CD8 ϩ T cells elicited was greater in response to administration of free live bacteria compared to live bacteria contained within DC. Administration of DC loaded with live bacteria, however, resulted in a higher level of cytolytic activity compared to that observed in mice given free live bacteria. This may reflect that the two assays measure distinct functions of T cells. In addition, the frequency of IFN-␥-producing CD8 ϩ T cells (Figs. 5, 6a , and 7a) reflects the total bacteriumspecific cell population, while the cytolytic activity measures OVA(257-264)/K b -specific T cells ( Fig. 6b and 7b) . Furthermore, the percentage of specific IFN-␥-producing CD8 ϩ T cells that have cytolytic activity is not known. The difference in the efficiency of eliciting specific T cells by the two immunization strategies (free live bacteria compared to live bacteria contained within DC) is not likely due to a different quantity of bacteria administered or persistence of the bacteria in vivo. That is, a similar amount of bacteria was given in each type of administration (ϳ10 6 ), and similar numbers of bacteria were recovered from the spleens of animals in both groups at the time of sacrifice (100 to 1,000 total bacteria per spleen, never exceeding a twofold difference between the groups).
We found that the optimal method for restimulating splenocytes from infected mice was using bone marrow-derived DC preloaded with heat-killed bacteria. Thus, the data quantitating the frequency of IFN-␥-producing T cells in response to Salmonella infection (Figs 5, 6a, and 7a) using this restimulation protocol measured reactivity to natural Salmonella antigens as well as recombinant OVA. In other experiments, splenocytes from infected mice were restimulated with lysates prepared from 4550 or 4550 OVA. This resulted in a lower but similar frequency of CD8 ϩ and CD4 ϩ T cells producing IFN-␥. However, within either T-cell subset, a similar frequency of IFN-␥-producing cells was detected regardless of whether the restimulating lysate contained OVA (data not shown). These data, combined with our inability to detect OVA(265-280)/I-A b -specific T cells in experiments where splenocytes from infected mice were restimulated with OVA(265-280) peptide, suggest that the majority of the IFN- The observed difference in T-cell priming efficiency in mice given free bacteria versus those administered within DC could, for example, result from different trafficking of injected DC versus free bacteria from the peritoneal cavity to secondary lymphoid organs. Alternatively, a different APC population presenting the bacteria administered free or contained within DC could contribute to the observed difference. The latter point raises the question of whether direct or indirect priming of host T cells occurs in mice given Salmonella-loaded DC. Preliminary data showed that Salmonella-specific IFN-␥-producing CD8 ϩ T cells were elicited in C57BL/6 mice given DC from TAP1 Ϫ ␤ 2 m Ϫ/Ϫ double-knockout mice loaded with heatkilled 4550 OVA (Yrlid et al., unpublished data). As these DC are unable to directly present Salmonella antigens to host CD8 ϩ T cells (19) , the data demonstrate that direct priming by the immunizing DC is not required to elicit CD8 ϩ effector cells. However, the relative contribution of direct versus indirect priming of T cells by Salmonella-loaded DC remains to be clarified. Taken together the data in the present study support a role for dendritic cells as an APC important in triggering a specific immune response during Salmonella infection. 
